Unichem Laboratories received ANDA popularity of its Quetiapine Extended-Release Tablets USP, 50 mg, a hundred and fifty mg, 200 mg, three hundred mg, and
400 mg from the USA Food and Drug Administration (USFDA) to marketplace a usual model of SEROQUEL XR (Quetiapine) Tablet, Extended Release, 50 mg, a hundred and fifty mg, two hundred mg, three hundred mg, and four hundred mg of AstraZeneca Pharmaceuticals LP.
Quetiapine Extended-Release Tablets are indicated for the treatment of Schizophrenia, Bipolar disease and adjunctive treatment of Major Depressive Disorder (MDD). The product could be commercialized from Unichem’s Goa Plant.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
